Hematopoietic Stem Cells Transplantation Industry Research Report 2023

Hematopoietic Stem Cells Transplantation Industry Research Report 2023


Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.

Highlights

The global Hematopoietic Stem Cells Transplantation market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Market competition is intense. CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Top 5 players accounted for about 32.09% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hematopoietic Stem Cells Transplantation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematopoietic Stem Cells Transplantation.
The Hematopoietic Stem Cells Transplantation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hematopoietic Stem Cells Transplantation market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematopoietic Stem Cells Transplantation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis

Product Type Insights

Global markets are presented by Hematopoietic Stem Cells Transplantation type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Hematopoietic Stem Cells Transplantation are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Hematopoietic Stem Cells Transplantation segment by Type

Stem Cells Storage
Stem Cells Consumables

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Hematopoietic Stem Cells Transplantation market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Hematopoietic Stem Cells Transplantation market.
Hematopoietic Stem Cells Transplantation Segment by Application

Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Hematopoietic Stem Cells Transplantation market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hematopoietic Stem Cells Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Hematopoietic Stem Cells Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Hematopoietic Stem Cells Transplantation industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hematopoietic Stem Cells Transplantation.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Hematopoietic Stem Cells Transplantation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Hematopoietic Stem Cells Transplantation by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Stem Cells Storage
1.2.3 Stem Cells Consumables
2.3 Hematopoietic Stem Cells Transplantation by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Leukemia
2.3.3 Lymphoproliferative Disorders
2.3.4 Solid Tumors
2.3.5 Non-Malignant Disorders
2.4 Assumptions and Limitations
3 Hematopoietic Stem Cells Transplantation Breakdown Data by Type
3.1 Global Hematopoietic Stem Cells Transplantation Historic Market Size by Type (2018-2023)
3.2 Global Hematopoietic Stem Cells Transplantation Forecasted Market Size by Type (2023-2028)
4 Hematopoietic Stem Cells Transplantation Breakdown Data by Application
4.1 Global Hematopoietic Stem Cells Transplantation Historic Market Size by Application (2018-2023)
4.2 Global Hematopoietic Stem Cells Transplantation Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Hematopoietic Stem Cells Transplantation Market Perspective (2018-2029)
5.2 Global Hematopoietic Stem Cells Transplantation Growth Trends by Region
5.2.1 Global Hematopoietic Stem Cells Transplantation Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Hematopoietic Stem Cells Transplantation Historic Market Size by Region (2018-2023)
5.2.3 Hematopoietic Stem Cells Transplantation Forecasted Market Size by Region (2024-2029)
5.3 Hematopoietic Stem Cells Transplantation Market Dynamics
5.3.1 Hematopoietic Stem Cells Transplantation Industry Trends
5.3.2 Hematopoietic Stem Cells Transplantation Market Drivers
5.3.3 Hematopoietic Stem Cells Transplantation Market Challenges
5.3.4 Hematopoietic Stem Cells Transplantation Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Hematopoietic Stem Cells Transplantation Players by Revenue
6.1.1 Global Top Hematopoietic Stem Cells Transplantation Players by Revenue (2018-2023)
6.1.2 Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Players (2018-2023)
6.2 Global Hematopoietic Stem Cells Transplantation Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Hematopoietic Stem Cells Transplantation Head office and Area Served
6.4 Global Hematopoietic Stem Cells Transplantation Players, Product Type & Application
6.5 Global Hematopoietic Stem Cells Transplantation Players, Date of Enter into This Industry
6.6 Global Hematopoietic Stem Cells Transplantation Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Hematopoietic Stem Cells Transplantation Market Size (2018-2029)
7.2 North America Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Hematopoietic Stem Cells Transplantation Market Size by Country (2018-2023)
7.4 North America Hematopoietic Stem Cells Transplantation Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Hematopoietic Stem Cells Transplantation Market Size (2018-2029)
8.2 Europe Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Hematopoietic Stem Cells Transplantation Market Size by Country (2018-2023)
8.4 Europe Hematopoietic Stem Cells Transplantation Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size (2018-2029)
9.2 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size by Country (2018-2023)
9.4 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Hematopoietic Stem Cells Transplantation Market Size (2018-2029)
10.2 Latin America Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Hematopoietic Stem Cells Transplantation Market Size by Country (2018-2023)
10.4 Latin America Hematopoietic Stem Cells Transplantation Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size (2018-2029)
11.2 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Country (2018-2023)
11.4 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 CBR Systems
11.1.1 CBR Systems Company Detail
11.1.2 CBR Systems Business Overview
11.1.3 CBR Systems Hematopoietic Stem Cells Transplantation Introduction
11.1.4 CBR Systems Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022)
11.1.5 CBR Systems Recent Development
11.2 China Cord Blood Corporation
11.2.1 China Cord Blood Corporation Company Detail
11.2.2 China Cord Blood Corporation Business Overview
11.2.3 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Introduction
11.2.4 China Cord Blood Corporation Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022)
11.2.5 China Cord Blood Corporation Recent Development
11.3 ViaCord
11.3.1 ViaCord Company Detail
11.3.2 ViaCord Business Overview
11.3.3 ViaCord Hematopoietic Stem Cells Transplantation Introduction
11.3.4 ViaCord Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022)
11.3.5 ViaCord Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Introduction
11.4.4 Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 STEMCELL Technologies
11.5.1 STEMCELL Technologies Company Detail
11.5.2 STEMCELL Technologies Business Overview
11.5.3 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Introduction
11.5.4 STEMCELL Technologies Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022)
11.5.5 STEMCELL Technologies Recent Development
11.6 Vcanbio
11.6.1 Vcanbio Company Detail
11.6.2 Vcanbio Business Overview
11.6.3 Vcanbio Hematopoietic Stem Cells Transplantation Introduction
11.6.4 Vcanbio Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022)
11.6.5 Vcanbio Recent Development
11.7 Merck Millipore
11.7.1 Merck Millipore Company Detail
11.7.2 Merck Millipore Business Overview
11.7.3 Merck Millipore Hematopoietic Stem Cells Transplantation Introduction
11.7.4 Merck Millipore Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022)
11.7.5 Merck Millipore Recent Development
11.8 Lonza Group
11.8.1 Lonza Group Company Detail
11.8.2 Lonza Group Business Overview
11.8.3 Lonza Group Hematopoietic Stem Cells Transplantation Introduction
11.8.4 Lonza Group Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022)
11.8.5 Lonza Group Recent Development
11.9 CellGenix Technologie Transfer
11.9.1 CellGenix Technologie Transfer Company Detail
11.9.2 CellGenix Technologie Transfer Business Overview
11.9.3 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Introduction
11.9.4 CellGenix Technologie Transfer Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022)
11.9.5 CellGenix Technologie Transfer Recent Development
11.10 ThermoGenesis
11.10.1 ThermoGenesis Company Detail
11.10.2 ThermoGenesis Business Overview
11.10.3 ThermoGenesis Hematopoietic Stem Cells Transplantation Introduction
11.10.4 ThermoGenesis Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022)
11.10.5 ThermoGenesis Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Hematopoietic Stem Cells Transplantation Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Type (2018-2023)
Table 7. Global Hematopoietic Stem Cells Transplantation Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Type (2024-2029)
Table 9. Global Hematopoietic Stem Cells Transplantation Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Application (2018-2023)
Table 11. Global Hematopoietic Stem Cells Transplantation Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Application (2024-2029)
Table 13. Global Hematopoietic Stem Cells Transplantation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Hematopoietic Stem Cells Transplantation Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Hematopoietic Stem Cells Transplantation Market Share by Region (2018-2023)
Table 16. Global Hematopoietic Stem Cells Transplantation Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Hematopoietic Stem Cells Transplantation Market Share by Region (2024-2029)
Table 18. Hematopoietic Stem Cells Transplantation Market Trends
Table 19. Hematopoietic Stem Cells Transplantation Market Drivers
Table 20. Hematopoietic Stem Cells Transplantation Market Challenges
Table 21. Hematopoietic Stem Cells Transplantation Market Restraints
Table 22. Global Top Hematopoietic Stem Cells Transplantation Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Hematopoietic Stem Cells Transplantation Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Hematopoietic Stem Cells Transplantation, Headquarters and Area Served
Table 26. Global Hematopoietic Stem Cells Transplantation Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Hematopoietic Stem Cells Transplantation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Hematopoietic Stem Cells Transplantation Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Hematopoietic Stem Cells Transplantation Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Hematopoietic Stem Cells Transplantation Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Hematopoietic Stem Cells Transplantation Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Hematopoietic Stem Cells Transplantation Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Hematopoietic Stem Cells Transplantation Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Hematopoietic Stem Cells Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Country (2024-2029) & (US$ Million)
Table 45. CBR Systems Company Detail
Table 46. CBR Systems Business Overview
Table 47. CBR Systems Hematopoietic Stem Cells Transplantation Product
Table 48. CBR Systems Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022) & (US$ Million)
Table 49. CBR Systems Recent Development
Table 50. China Cord Blood Corporation Company Detail
Table 51. China Cord Blood Corporation Business Overview
Table 52. China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Product
Table 53. China Cord Blood Corporation Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022) & (US$ Million)
Table 54. China Cord Blood Corporation Recent Development
Table 55. ViaCord Company Detail
Table 56. ViaCord Business Overview
Table 57. ViaCord Hematopoietic Stem Cells Transplantation Product
Table 58. ViaCord Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022) & (US$ Million)
Table 59. ViaCord Recent Development
Table 60. Thermo Fisher Scientific Company Detail
Table 61. Thermo Fisher Scientific Business Overview
Table 62. Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Product
Table 63. Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022) & (US$ Million)
Table 64. Thermo Fisher Scientific Recent Development
Table 65. STEMCELL Technologies Company Detail
Table 66. STEMCELL Technologies Business Overview
Table 67. STEMCELL Technologies Hematopoietic Stem Cells Transplantation Product
Table 68. STEMCELL Technologies Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022) & (US$ Million)
Table 69. STEMCELL Technologies Recent Development
Table 70. Vcanbio Company Detail
Table 71. Vcanbio Business Overview
Table 72. Vcanbio Hematopoietic Stem Cells Transplantation Product
Table 73. Vcanbio Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022) & (US$ Million)
Table 74. Vcanbio Recent Development
Table 75. Merck Millipore Company Detail
Table 76. Merck Millipore Business Overview
Table 77. Merck Millipore Hematopoietic Stem Cells Transplantation Product
Table 78. Merck Millipore Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022) & (US$ Million)
Table 79. Merck Millipore Recent Development
Table 80. Lonza Group Company Detail
Table 81. Lonza Group Business Overview
Table 82. Lonza Group Hematopoietic Stem Cells Transplantation Product
Table 83. Lonza Group Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022) & (US$ Million)
Table 84. Lonza Group Recent Development
Table 85. CellGenix Technologie Transfer Company Detail
Table 86. CellGenix Technologie Transfer Business Overview
Table 87. CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Product
Table 88. CellGenix Technologie Transfer Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022) & (US$ Million)
Table 89. CellGenix Technologie Transfer Recent Development
Table 90. ThermoGenesis Company Detail
Table 91. ThermoGenesis Business Overview
Table 92. ThermoGenesis Hematopoietic Stem Cells Transplantation Product
Table 93. ThermoGenesis Revenue in Hematopoietic Stem Cells Transplantation Business (2017-2022) & (US$ Million)
Table 94. ThermoGenesis Recent Development
Table 95. CBR Systems Company Information
Table 96. CBR Systems Business Overview
Table 97. CBR Systems Hematopoietic Stem Cells Transplantation Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million)
Table 98. CBR Systems Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million) Portfolio
Table 99. CBR Systems Recent Development
Table 100. China Cord Blood Corporation Company Information
Table 101. China Cord Blood Corporation Business Overview
Table 102. China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million)
Table 103. China Cord Blood Corporation Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million) Portfolio
Table 104. China Cord Blood Corporation Recent Development
Table 105. ViaCord Company Information
Table 106. ViaCord Business Overview
Table 107. ViaCord Hematopoietic Stem Cells Transplantation Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million)
Table 108. ViaCord Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million) Portfolio
Table 109. ViaCord Recent Development
Table 110. Thermo Fisher Scientific Company Information
Table 111. Thermo Fisher Scientific Business Overview
Table 112. Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million)
Table 113. Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million) Portfolio
Table 114. Thermo Fisher Scientific Recent Development
Table 115. STEMCELL Technologies Company Information
Table 116. STEMCELL Technologies Business Overview
Table 117. STEMCELL Technologies Hematopoietic Stem Cells Transplantation Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million)
Table 118. STEMCELL Technologies Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million) Portfolio
Table 119. STEMCELL Technologies Recent Development
Table 120. Vcanbio Company Information
Table 121. Vcanbio Business Overview
Table 122. Vcanbio Hematopoietic Stem Cells Transplantation Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million)
Table 123. Vcanbio Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million) Portfolio
Table 124. Vcanbio Recent Development
Table 125. Merck Millipore Company Information
Table 126. Merck Millipore Business Overview
Table 127. Merck Millipore Hematopoietic Stem Cells Transplantation Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million)
Table 128. Merck Millipore Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million) Portfolio
Table 129. Merck Millipore Recent Development
Table 130. Lonza Group Company Information
Table 131. Lonza Group Business Overview
Table 132. Lonza Group Hematopoietic Stem Cells Transplantation Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million)
Table 133. Lonza Group Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million) Portfolio
Table 134. Lonza Group Recent Development
Table 135. CellGenix Technologie Transfer Company Information
Table 136. CellGenix Technologie Transfer Business Overview
Table 137. CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million)
Table 138. CellGenix Technologie Transfer Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million) Portfolio
Table 139. CellGenix Technologie Transfer Recent Development
Table 140. ThermoGenesis Company Information
Table 141. ThermoGenesis Business Overview
Table 142. ThermoGenesis Hematopoietic Stem Cells Transplantation Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million)
Table 143. ThermoGenesis Revenue in Hematopoietic Stem Cells Transplantation Business (2018-2023) & (US$ Million) Portfolio
Table 144. ThermoGenesis Recent Development
Table 145. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Hematopoietic Stem Cells Transplantation Product Picture
Figure 5. Global Hematopoietic Stem Cells Transplantation Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Hematopoietic Stem Cells Transplantation Market Share by Type: 2022 VS 2029
Figure 7. Stem Cells Storage Product Picture
Figure 8. Stem Cells Consumables Product Picture
Figure 9. Global Hematopoietic Stem Cells Transplantation Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Hematopoietic Stem Cells Transplantation Market Share by Application: 2022 VS 2029
Figure 11. Leukemia Product Picture
Figure 12. Lymphoproliferative Disorders Product Picture
Figure 13. Solid Tumors Product Picture
Figure 14. Non-Malignant Disorders Product Picture
Figure 15. Global Hematopoietic Stem Cells Transplantation Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Hematopoietic Stem Cells Transplantation Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Hematopoietic Stem Cells Transplantation Market Share by Region: 2022 VS 2029
Figure 18. Global Hematopoietic Stem Cells Transplantation Market Share by Players in 2022
Figure 19. Global Hematopoietic Stem Cells Transplantation Players, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Hematopoietic Stem Cells Transplantation Players Market Share by Revenue in 2022
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. North America Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Hematopoietic Stem Cells Transplantation Market Share by Country (2018-2029)
Figure 24. United States Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Hematopoietic Stem Cells Transplantation Market Share by Country (2018-2029)
Figure 28. Germany Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Hematopoietic Stem Cells Transplantation Market Share by Country (2018-2029)
Figure 36. China Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Hematopoietic Stem Cells Transplantation Market Share by Country (2018-2029)
Figure 44. Mexico Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Hematopoietic Stem Cells Transplantation Market Share by Country (2018-2029)
Figure 48. Turkey Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. UAE Hematopoietic Stem Cells Transplantation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. CBR Systems Revenue Growth Rate in Hematopoietic Stem Cells Transplantation Business (2018-2023)
Figure 52. China Cord Blood Corporation Revenue Growth Rate in Hematopoietic Stem Cells Transplantation Business (2018-2023)
Figure 53. ViaCord Revenue Growth Rate in Hematopoietic Stem Cells Transplantation Business (2018-2023)
Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Hematopoietic Stem Cells Transplantation Business (2018-2023)
Figure 55. STEMCELL Technologies Revenue Growth Rate in Hematopoietic Stem Cells Transplantation Business (2018-2023)
Figure 56. Vcanbio Revenue Growth Rate in Hematopoietic Stem Cells Transplantation Business (2018-2023)
Figure 57. Merck Millipore Revenue Growth Rate in Hematopoietic Stem Cells Transplantation Business (2018-2023)
Figure 58. Lonza Group Revenue Growth Rate in Hematopoietic Stem Cells Transplantation Business (2018-2023)
Figure 59. CellGenix Technologie Transfer Revenue Growth Rate in Hematopoietic Stem Cells Transplantation Business (2018-2023)
Figure 60. ThermoGenesis Revenue Growth Rate in Hematopoietic Stem Cells Transplantation Business (2018-2023)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings